184 related articles for article (PubMed ID: 37114479)
1. IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.
Gardella E; Michelucci R; Christensen HM; Fenger CD; Reale C; Riguzzi P; Pasini E; Albini-Riccioli L; Papa V; Foschini MP; Cenacchi G; Furia F; Marjanovic D; Hammer TB; Møller RS; Rubboli G
Epilepsia; 2023 Aug; 64(8):e170-e176. PubMed ID: 37114479
[TBL] [Abstract][Full Text] [Related]
2. IRF2BPL: A new genotype for progressive myoclonus epilepsies.
Costa C; Oliver KL; Calvello C; Cameron JM; Imperatore V; Tonelli L; Colavito D; Franceschetti S; Canafoglia L; Berkovic SF; Prontera P
Epilepsia; 2023 Aug; 64(8):e164-e169. PubMed ID: 36810721
[TBL] [Abstract][Full Text] [Related]
3. Novel NUS1 variant in a Chinese patient with progressive myoclonus epilepsy: a case report and systematic review.
Ji C; Zhao J; Zhang J; Wang K
Neurol Sci; 2023 Oct; 44(10):3495-3498. PubMed ID: 37249665
[TBL] [Abstract][Full Text] [Related]
4. Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes.
Castellotti B; Canafoglia L; Freri E; Tappatà M; Messina G; Magri S; DiFrancesco JC; Fanella M; Di Bonaventura C; Morano A; Granata T; Gellera C; Franceschetti S; Michelucci R
Epilepsia Open; 2023 Jun; 8(2):645-650. PubMed ID: 36719163
[TBL] [Abstract][Full Text] [Related]
5. Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL.
Qian XH; Liu XY; Zhu ZY; Wang SG; Song XX; Chen G; Wu JY; Tang HD; Cao L
Seizure; 2021 Jan; 84():47-52. PubMed ID: 33278788
[TBL] [Abstract][Full Text] [Related]
6. IRF2BPL gene variants with dystonia: one new Chinese case report.
Yang F; Li H; Dai Y; Zhang R; Zhang JT
BMC Neurol; 2023 Jan; 23(1):32. PubMed ID: 36670390
[TBL] [Abstract][Full Text] [Related]
7. A very rare form of autosomal dominant progressive myoclonus epilepsy caused by a novel variant in the PRICKLE1 gene.
Algahtani H; Al-Hakami F; Al-Shehri M; Shirah B; Al-Qahtani MH; Abdulkareem AA; Naseer MI
Seizure; 2019 Jul; 69():133-139. PubMed ID: 31035234
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of IRF2BPL in a Taiwanese dystonia cohort: The genotype and phenotype correlation.
Chen PS; Chen YF; Chiu JY; Wu MC; Tai CH; Chang YY; Lan MY; Lee NC; Lin CH
Ann Clin Transl Neurol; 2024 Jun; 11(6):1557-1566. PubMed ID: 38650104
[TBL] [Abstract][Full Text] [Related]
9. De novo variants of IRF2BPL result in developmental epileptic disorder.
Wang Y; Ke Z; Li Y; Qiu M; Liu J; Yang Z; Wen S; Liang M; Chen S
Orphanet J Rare Dis; 2024 Mar; 19(1):121. PubMed ID: 38481258
[TBL] [Abstract][Full Text] [Related]
10. Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review.
Tian WT; Liu XL; Xu YQ; Huang XJ; Zhou HY; Wang Y; Tang HD; Chen SD; Luan XH; Cao L
Seizure; 2018 Apr; 57():80-86. PubMed ID: 29605618
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenic gene variants and clinical phenotype features of 26 children with progressive myoclonic epilepsy].
Zhang J; Zhang YH; Chen JY; Ji TY; Yang ZX; Yang XL; Sun W; Zhang LP; Wu XR
Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):458-464. PubMed ID: 31216804
[No Abstract] [Full Text] [Related]
12. A novel IRF2BPL truncating variant is associated with endolysosomal storage.
Ginevrino M; Battini R; Nuovo S; Simonati A; Micalizzi A; Contaldo I; Serpieri V; Valente EM
Mol Biol Rep; 2020 Jan; 47(1):711-714. PubMed ID: 31583567
[TBL] [Abstract][Full Text] [Related]
13. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
Nascimento FA; Andrade DM
Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
[TBL] [Abstract][Full Text] [Related]
14. IRF2BPL gene mutation: Expanding on neurologic phenotypes.
Shelkowitz E; Singh JK; Larson A; Elias ER
Am J Med Genet A; 2019 Nov; 179(11):2263-2271. PubMed ID: 31432588
[TBL] [Abstract][Full Text] [Related]
15. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene.
Kousi M; Anttila V; Schulz A; Calafato S; Jakkula E; Riesch E; Myllykangas L; Kalimo H; Topçu M; Gökben S; Alehan F; Lemke JR; Alber M; Palotie A; Kopra O; Lehesjoki AE
J Med Genet; 2012 Jun; 49(6):391-9. PubMed ID: 22693283
[TBL] [Abstract][Full Text] [Related]
16. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy.
Tran Mau-Them F; Guibaud L; Duplomb L; Keren B; Lindstrom K; Marey I; Mochel F; van den Boogaard MJ; Oegema R; Nava C; Masurel A; Jouan T; Jansen FE; Au M; Chen AH; Cho M; Duffourd Y; Lozier E; Konovalov F; Sharkov A; Korostelev S; Urteaga B; Dickson P; Vera M; Martínez-Agosto JA; Begemann A; Zweier M; Schmitt-Mechelke T; Rauch A; Philippe C; van Gassen K; Nelson S; Graham JM; Friedman J; Faivre L; Lin HJ; Thauvin-Robinet C; Vitobello A
Genet Med; 2019 Apr; 21(4):1008-1014. PubMed ID: 30166628
[TBL] [Abstract][Full Text] [Related]
17. Progressive myoclonus epilepsy and ceroidolipofuscinosis 14: The multifaceted phenotypic spectrum of KCTD7-related disorders.
Mastrangelo M; Sartori S; Simonati A; Brinciotti M; Moro F; Nosadini M; Pezzini F; Doccini S; Santorelli FM; Leuzzi V
Eur J Med Genet; 2019 Dec; 62(12):103591. PubMed ID: 30500434
[TBL] [Abstract][Full Text] [Related]
18. KCTD7-related progressive myoclonic epilepsy: Report of 42 cases and review of literature.
Yoganathan S; Whitney R; Thomas M; Danda S; Chettali AM; Prasad AN; Farhan SMK; AlSowat D; Abukhaled M; Aldhalaan H; Gowda VK; Kinhal UV; Bylappa AY; Konanki R; Lingappa L; Parchuri BM; Appendino JP; Scantlebury MH; Cunningham J; Hadjinicolaou A; El Achkar CM; Kamate M; Menon RN; Jose M; Riordan G; Kannan L; Jain V; Manokaran RK; Chau V; Donner EJ; Costain G; Minassian BA; Jain P
Epilepsia; 2024 Mar; 65(3):709-724. PubMed ID: 38231304
[TBL] [Abstract][Full Text] [Related]
19. Conventional and novel anti-seizure medications reveal a particular role for GABA
Polet SS; de Koning TJ; Lambrechts RA; Tijssen MAJ; Sibon OCM; Gorter JA
Epilepsy Res; 2024 Jul; 203():107380. PubMed ID: 38781737
[TBL] [Abstract][Full Text] [Related]
20. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.
Rubboli G; Franceschetti S; Berkovic SF; Canafoglia L; Gambardella A; Dibbens LM; Riguzzi P; Campieri C; Magaudda A; Tassinari CA; Michelucci R
Epilepsia; 2011 Dec; 52(12):2356-63. PubMed ID: 22050460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
